Cancer - Werewolf Therapeutics, Inc.
Cancer
Status:
Active, open to accrualClinicalTrials.gov:
NCT05678998A Phase 1 (First-In-Human [FIH]), Multi-Site, Dose Escalation and Expansion Study of WTX-330 in Adult Patients with Advanced or Metastatic Solid Tumors or Lymphoma